EP3373959
ARENAVEIRUAGNIR SEM KRABBAMEINSBÓLUEFNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.11.2016EP published:
29.6.2022EP application number:
16797775.0
EP translation filed:
9.9.2022Grant published:
15.10.2022EPO information:
European Patent Register
Max expiry date:
3.11.2036Expiry date:
3.11.2026Next due date:
30.11.2026
Title in English:
ARENAVIRUS PARTICLES AS CANCER VACCINESLanguage of the patent:
English
Timeline
Today
4.11.2016EP application
29.6.2022EP Publication
9.9.2022Translation submitted
15.10.2022Registration published
3.11.2026Expires
Owner
Name:
Hookipa Biotech GmbHAddress:
Helmut-Qualtinger-Gasse 2, 1030 Wien, AT
Inventor
Name:
SCHMIDT, SarahAddress:
1190 Vienna, AT
Name:
ORLINGER, KlausAddress:
1190 Wien, AT
Name:
COHEN, KatherineAddress:
1070 Wien, AT
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562254654 PDate:
12.11.2015Country:
US
Number:
201562254651 PDate:
12.11.2015Country:
US
Classification
Categories:
A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 11.11.2022
Expires: 3.11.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 11.11.2022
Expires: 3.11.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 11.11.2022
Expires: 3.11.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 8
Paid: 10.11.2023
Expires: 3.11.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 8
Paid: 10.11.2023
Expires: 3.11.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 12.11.2024
Expires: 3.11.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 11.11.2025
Expires: 3.11.2026
Payer: G.H. Sigurgeirsson ehf.